Last reviewed · How we verify

Product 2 - AquaCelle Fish Oil Ethyl Ester

RDC Clinical Pty Ltd · FDA-approved active Small molecule

Product 2 - AquaCelle Fish Oil Ethyl Ester is a Omega-3 fatty acid supplement / Triglyceride-lowering agent Small molecule drug developed by RDC Clinical Pty Ltd. It is currently FDA-approved for Hypertriglyceridemia management, Cardiovascular health support.

AquaCelle Fish Oil Ethyl Ester provides omega-3 polyunsaturated fatty acids (EPA and DHA) that reduce triglycerides and support cardiovascular health.

AquaCelle Fish Oil Ethyl Ester provides omega-3 polyunsaturated fatty acids (EPA and DHA) that reduce triglycerides and support cardiovascular health. Used for Hypertriglyceridemia management, Cardiovascular health support.

At a glance

Generic nameProduct 2 - AquaCelle Fish Oil Ethyl Ester
SponsorRDC Clinical Pty Ltd
Drug classOmega-3 fatty acid supplement / Triglyceride-lowering agent
TargetMultiple targets including PPAR-alpha, GPR120, and hepatic lipid metabolism pathways
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Fish oil ethyl esters are concentrated forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) derived from fish sources. These omega-3 fatty acids work by reducing hepatic triglyceride synthesis, increasing fatty acid oxidation, and modulating inflammatory pathways, thereby lowering serum triglyceride levels and supporting cardiovascular function.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Product 2 - AquaCelle Fish Oil Ethyl Ester

What is Product 2 - AquaCelle Fish Oil Ethyl Ester?

Product 2 - AquaCelle Fish Oil Ethyl Ester is a Omega-3 fatty acid supplement / Triglyceride-lowering agent drug developed by RDC Clinical Pty Ltd, indicated for Hypertriglyceridemia management, Cardiovascular health support.

How does Product 2 - AquaCelle Fish Oil Ethyl Ester work?

AquaCelle Fish Oil Ethyl Ester provides omega-3 polyunsaturated fatty acids (EPA and DHA) that reduce triglycerides and support cardiovascular health.

What is Product 2 - AquaCelle Fish Oil Ethyl Ester used for?

Product 2 - AquaCelle Fish Oil Ethyl Ester is indicated for Hypertriglyceridemia management, Cardiovascular health support.

Who makes Product 2 - AquaCelle Fish Oil Ethyl Ester?

Product 2 - AquaCelle Fish Oil Ethyl Ester is developed and marketed by RDC Clinical Pty Ltd (see full RDC Clinical Pty Ltd pipeline at /company/rdc-clinical-pty-ltd).

What drug class is Product 2 - AquaCelle Fish Oil Ethyl Ester in?

Product 2 - AquaCelle Fish Oil Ethyl Ester belongs to the Omega-3 fatty acid supplement / Triglyceride-lowering agent class. See all Omega-3 fatty acid supplement / Triglyceride-lowering agent drugs at /class/omega-3-fatty-acid-supplement-triglyceride-lowering-agent.

What development phase is Product 2 - AquaCelle Fish Oil Ethyl Ester in?

Product 2 - AquaCelle Fish Oil Ethyl Ester is FDA-approved (marketed).

What are the side effects of Product 2 - AquaCelle Fish Oil Ethyl Ester?

Common side effects of Product 2 - AquaCelle Fish Oil Ethyl Ester include Gastrointestinal upset (nausea, dyspepsia), Fish aftertaste, Bleeding tendency (at high doses).

What does Product 2 - AquaCelle Fish Oil Ethyl Ester target?

Product 2 - AquaCelle Fish Oil Ethyl Ester targets Multiple targets including PPAR-alpha, GPR120, and hepatic lipid metabolism pathways and is a Omega-3 fatty acid supplement / Triglyceride-lowering agent.

Related